WebDec 1, 2014 · Physical examination includes a digital rectal examination and assessment for bladder distention or neurologic impairment. Recommended tests include serum prostate-specific antigen measurement... WebSerum TPS and PSA levels were determined in 128 patients (pts) with benign prostatic hypertrophy (BPH; Group 1) and in 92 pts with prostate cancer (Group 2). TPS was also measured in a control group of 100 healthy subjects. Normal cutoff values of 85 U/l for TPS and 4 ng/ml for PSA were determined on the basis of ROC curve analysis.
Benign prostatic hyperplasia (BPH) - Diagnosis and …
WebMar 22, 2024 · Benign prostatic hyperplasia (BPH), also known as benign prostatic hypertrophy, is a histologic diagnosis characterized by proliferation of the cellular … WebObjective: To perform head-to-head comparisons of PSMA-PET and CIM including multiparametric magnetic resonance imaging (mpMRI), computed tomography (CT) and bone scan (BS) for upfront staging of tumour, nodal, and bone metastasis. hi ich bin jo
Prostate Cancer Treatment with Laser Focal Therapy HALO
WebBenign prostatic hyperplasia (BPH), or benign prostatic hypertrophy, is an enlargement of the prostate, a walnut-sized gland that forms part of the male reproductive system. … WebApr 7, 2024 · Prostate cancer is categorized into four stages that indicate severity and spread. Stages 1 and 2 are known as localized or early-stage cancer; stage 3 is called locally advanced cancer, and stage 4, or advanced cancer, is the most severe. 2 If identified and treated promptly, most cases of prostate cancer can be effectively managed. WebBackground: Prostate cancer (PCa) is the second leading cause of cancer death in men. Several articles have reported that microRNA-21 (miR-21) and microRNA-30c (miR-30c) have diagnostic values for PCa, but the results are inconclusive. In order to precisely assess the diagnostic values of miR-21 and miR-30c for PCa, this meta-analysis is … hi igitur illis deabus heri gratias agebant